JAK2 and myelofibrosis: This sets up a vicious cycle in which the poor negative response inhibition of the JAK2 mutation clone by inflammatory cytokine TNF-α [35] produces more ROS, inducing more genetic alteration changes that eventually lead to the development of myelofibrosis or leukemia, as proposed by Hasselbalch [36].